Finance

Lists
Why is SVNS up 4,76%?
Dive Deeper
SVNS:LON
Solvonis Therapeutics PLC
GBX 0,11
+4,76%
(+0,0050) 1D
15 Okt., 11:40:46 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for SVNS...
Open
GBX 0,11
High
GBX 0,11
Low
GBX 0,10
Mkt. cap
8,33 m
Avg. vol.
25,42 m
Volume
18,10 m
52-wk high
GBX 0,39
52-wk low
GBX 0,10
EPS
-GBX 0,00
Shares outstanding
7,90 mjd
No. of employees
6
Open
GBX 0,11
High
GBX 0,11
Low
GBX 0,10
Mkt. cap
8,33 m
Avg. vol.
25,42 m
Volume
18,10 m
52-wk high
GBX 0,39
52-wk low
GBX 0,10
EPS
-GBX 0,00
Shares outstanding
7,90 mjd
No. of employees
6
News stories
From web sources and news partners
About Solvonis Therapeutics PLC
CEO-
Employees6
Founded2017
Headquarters-
Sector-
Websitesolvonis.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
213,00 k
213,00 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
699,50 k
699,50 k
505,50 k
505,50 k
Operating expense
979,00 k
979,00 k
718,50 k
718,50 k
Total operating expenses
979,00 k
979,00 k
718,50 k
718,50 k
Operating income
-979,00 k
-979,00 k
-718,50 k
-718,50 k
Other non operating income
-
-
-
-
EBT including unusual items
-2,06 m
-2,06 m
-718,50 k
-718,50 k
EBT excluding unusual items
-928,00 k
-928,00 k
-718,50 k
-718,50 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,06 m
-2,06 m
-718,50 k
-718,50 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2,00 k
2,00 k
-
-
Interest expense
-
-
-
-
Net interest expenses
2,00 k
2,00 k
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme